The experts who attended
Dedicated professionals committed to clinical excellence.
Meet Southern Star Research at the 2026 ARCS Annual Conference
Southern Star Research is proud to attend the 2026 ARCS Annual Conference, one of Australia’s leading events for the clinical research and healthcare innovation community.
This pivotal national event brings together professionals, researchers, academics and consumers for three days of learning, collaboration and networking. With a focus on advancing medicines, medical technologies and healthcare innovation, ARCS provides an important platform for discussing the future of clinical research across Australia and the Asia-Pacific region.
Connect With Southern Star Research
At Southern Star Research, we partner with biotech, pharmaceutical and medical device companies to deliver high-quality clinical development programs with agility, insight and precision.
Whether you are planning an early-phase study, scaling a global program or looking for a strategic CRO partner in Australia and APAC, our team would welcome the opportunity to connect during ARCS 2026.
Presentation Session
Teresa Ringeri, Director – Strategy Coordination will present:
Unlocking Innovation in Early-Phase Trials: The Australian Advantage
📅 11 June 2026 from 11:45-12:15 pm
Join Teresa as she explores how Australia’s clinical research ecosystem enables innovative early-phase development through regulatory efficiencies, world-class research infrastructure and access to experienced trial networks.
How We Accelerate Your Clinical Development
- Proactive Partnership: We commit to engaging intellectually and energetically with our clients’ challenges. Our teams apply foresight, critical thinking and domain expertise to anticipate obstacles and contribute meaningfully to the trial’s success.
- Embedded Quality: We define quality not just by compliance, but by the consistent application of judgment, rigor, and thoughtful planning throughout all stages of the clinical trial process.
- Tailored Execution: Our flexible, hands-on approach means your study is designed for both scientific and commercial success – tailored to your strategy, timelines and endpoints.
As the most complete mid-sized CRO in the APAC region , our team brings deep therapeutic experience, strong regulatory awareness, and longstanding site relationships to support your first-in-human, first-in-patient or Phase 2 study. We focus on delivering high-quality data that not only meets international regulatory standards—including the FDA, EMA, PMDA and Health Canada—but also strengthens your path to partnerships, licensing and future funding.
Recognised Industry Leadership
Southern Star Research continues to be recognised for excellence across the clinical research industry, including:
- Best CRO in Australia 2026
- Great Place to Work Certified 2024 and 2025
- APAC CRO of the Year 2025
- NSW Exporter of the Year 2025
- Frost & Sullivan Asia-Pacific Competitive Strategy Leadership Award 2024
- ISO 9001 Quality Assurance 2024 and 2025
Meet Our Team at ARCS 2026
We look forward to connecting with sponsors, partners and industry leaders throughout the conference.
To arrange a meeting with the Southern Star Research team during ARCS 2026, contact us to schedule a conversation.